F-star Therapeutics, Inc. Common Stock
FSTX
FSTX was delisted on the 8th of March, 2023.
3 hedge funds and large institutions have $14K invested in F-star Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
40% less funds holding
Funds holding: 5 → 3 (-2)
99% less capital invested
Capital invested by funds: $1.08M → $14K (-$1.07M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$1.06M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.44K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $8K | -$9.44K | -219 | -55% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $4K | +$1.64K | +38 | +76% |
|
|
BIM
3
BlackRock Investment Management
Wilmington,
Delaware
| $2K | – | – | – |
|
|
PCM
4
Parsons Capital Management
Providence,
Rhode Island
| – | -$1.06M | -27,953 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$4K | -94 | Closed |
|
FSTX Hedge Fund Activity: Q3 2016 in Review
3 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q3 2016, worth a combined $14K — down 99% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FSTX and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $1.64K. The largest seller was Parsons Capital Management, exiting entirely with an estimated $1.06M sold.
- 3 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q3 2016, down from 5 in Q2 2016.
- Funds reported $14K of F-star Therapeutics, Inc. Common Stock stock for Q3 2016, down 99% quarter-over-quarter.
- 0 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q3 2016 and 2 closed out, a net change of -2 holders.
- The largest F-star Therapeutics, Inc. Common Stock buyer in Q3 2016 was Bank of America, an estimated $1.64K added.
- The largest F-star Therapeutics, Inc. Common Stock seller in Q3 2016 was Parsons Capital Management, an estimated $1.06M sold.
Based on aggregated 13F filings for Q3 2016.